Clinical Trial Update: Evaluation of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma and Ocular Hypertension [Phase 3]

View source ↗

Summary

Phase 3 study evaluating netarsudil ophthalmic solution in ocular hypertension and open-angle glaucoma completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Netarsudil (netarsudil)

Snippet

Sponsor: Aerie Pharmaceuticals | Conditions: Ocular Hypertension, Open-angle Glaucoma | Phase 3 | Status: COMPLETED | Results posted: 2018-04-06